Pazopanib diminishes non-small cell lung cancer (NSCLC) growth and metastases in vivo

Honglin Zhao,Fan Yang,Wang Shen,Yuli Wang,Xuebing Li,Jiacong You,Qinghua Zhou

Pazopanib diminishes non-small cell lung cancer (NSCLC) growth and metastases in vivo

2015

Honglin Zhao
Fan Yang
Wang Shen
Yuli Wang
Xuebing Li
Jiacong You
Qinghua Zhou

Background Anti-angiogenesis has been demonstrated to have a critical role in lung cancer pathogenesis. Here, we characterized the effect of the small-molecule angiogenesis inhibitor pazopanib on non-small cell lung cancer (NSCLC) cells.

Keywords:

Pathology
non-small cell lung cancer (NSCLC)
Medicine
Pazopanib
Pathogenesis
Angiogenesis inhibitor
In vivo
Bioluminescence imaging
Lung cancer
non small cell

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations